Literature DB >> 21686692

Isolated cytochrome c oxidase deficiency as a cause of MELAS.

Walter Rossmanith1, Michael Freilinger, Julia Roka, Thomas Raffelsberger, Karin Moser-Their, Daniela Prayer, Günther Bernert, Reginald Bittner.   

Abstract

Deletion of a single nucleotide (7630delT) within MT-CO2, the gene of subunit II of cytochrome c oxidase (COX), was identified in a clinically typical MELAS case. The deletion-induced frameshift results in a stop codon close to the 5' end of the reading frame. The lack of subunit II (COII) precludes the assembly of COX and leads to the degradation of unassembled subunits, even those not directly affected by the mutation. Despite mitochondrial proliferation and transcriptional upregulation of nuclear and mtDNA-encoded COX genes (including MT-CO2), a severe COX deficiency was found with all investigations of the muscle biopsy (histochemistry, biochemistry, immunoblotting). The 7630delT mutation in MT-CO2 leads to a lack of COII with subsequent misassembly and degradation of respiratory complex IV despite transcriptional upregulation of its subunits. The genetic and pathobiochemical heterogeneity of MELAS appears to be greater than previously appreciated.

Entities:  

Year:  2009        PMID: 21686692      PMCID: PMC3027970          DOI: 10.1136/bcr.08.2008.0666

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  24 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  Elimination of primer-dimer artifacts and genomic coamplification using a two-step SYBR green I real-time RT-PCR.

Authors:  Jo Vandesompele; Anne De Paepe; Frank Speleman
Journal:  Anal Biochem       Date:  2002-04-01       Impact factor: 3.365

Review 3.  Diagnosis and management of MELAS.

Authors:  Madhav Thambisetty; Nancy J Newman
Journal:  Expert Rev Mol Diagn       Date:  2004-09       Impact factor: 5.225

Review 4.  The diagnosis of mitochondrial muscle disease.

Authors:  Robert W Taylor; Andrew M Schaefer; Martin J Barron; Robert McFarland; Douglass M Turnbull
Journal:  Neuromuscul Disord       Date:  2004-04       Impact factor: 4.296

5.  Mutations of the mitochondrial ND1 gene as a cause of MELAS.

Authors:  D M Kirby; R McFarland; A Ohtake; C Dunning; M T Ryan; C Wilson; D Ketteridge; D M Turnbull; D R Thorburn; R W Taylor
Journal:  J Med Genet       Date:  2004-10       Impact factor: 6.318

Review 6.  Biogenesis of cytochrome c oxidase.

Authors:  Oleh Khalimonchuk; Gerhard Rödel
Journal:  Mitochondrion       Date:  2005-09-29       Impact factor: 4.160

7.  Strongly succinate dehydrogenase-reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.

Authors:  H Hasegawa; T Matsuoka; Y Goto; I Nonaka
Journal:  Ann Neurol       Date:  1991-06       Impact factor: 10.422

8.  Detection and quantification of point mutations in mitochondrial DNA by PCR.

Authors:  M Yoneda; Y Tanno; S Tsuji; G Attardi
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

Review 9.  The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.

Authors:  Fernando Scaglia; Jennifer L Northrop
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

10.  Clinical features of MELAS and mitochondrial DNA mutations.

Authors:  Y Goto
Journal:  Muscle Nerve Suppl       Date:  1995
View more
  1 in total

1.  Estrogenic regulation of skeletal muscle proteome: a study of premenopausal women and postmenopausal MZ cotwins discordant for hormonal therapy.

Authors:  Eija K Laakkonen; Rabah Soliymani; Sira Karvinen; Jaakko Kaprio; Urho M Kujala; Marc Baumann; Sarianna Sipilä; Vuokko Kovanen; Maciej Lalowski
Journal:  Aging Cell       Date:  2017-09-07       Impact factor: 9.304

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.